TROUSIL SEBASTIAN enters CITY THERAPEUTICS, INC. with 534.51K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/16/2026ACC: 0001104659-26-116358
Officer· Chief Operating Officer
Since Oct 2026
534.51K
Baseline shares
100% direct
534.51K
Direct ownership
1 position
46.29K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned534.51K
Total
534.51K direct534.51K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 534.51K | Direct |
| Total | 534.51K | 534.51K direct |
Derivative Holdings2
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
9.88K
Shares owned
N/A
Exercise price
0.92
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
36.41K
Shares owned
N/A
Exercise price
5.36
Expiration
—
Exercise window
—
Total
Underlying
46.29K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 0.92 | — | — | 9.88K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 5.36 | — | — | 36.41K | N/A |
| Total | 46.29K | 0.00 | ||||